Alpa Laboratories Soars with Record Highs
Alpa Laboratories, a leading pharmaceutical company in the microcap sector, has seen a surge in its stock price, reaching an all-time high of Rs.112.4 on January 2nd, 2024. With a Strong Buy rating from MarketsMojo, the company's financials and growth potential are highly regarded. Its recent performance has outperformed the sector and its stock is trading above its moving averages, indicating a positive sentiment in the market. Alpa Laboratories' success can be attributed to its strong management team, innovative products, and strategic partnerships. Its 1-year performance has been impressive, making it a top player in the pharma industry.
Alpa Laboratories, a leading pharmaceutical company in the microcap sector, has been making waves in the stock market with its recent performance. On January 2nd, 2024, the company's stock price reached an all-time high of Rs.112.4, which is a significant milestone for the company.
According to MarketsMOJO, a leading stock market analysis platform, Alpa Laboratories' stock has been given a "Strong Buy" rating. This is a testament to the company's strong financials and growth potential.
In terms of performance, Alpa Laboratories has outperformed the sector by 5.56% and has been on a consecutive gain for the past 2 days, with a 8.37% increase in returns. The stock also touched an intraday high of Rs.112.4, showing a strong upward trend.
Moreover, Alpa Laboratories is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive sentiment in the market towards the company.
In the pharma sector, Alpa Laboratories has gained by 2.31%, further solidifying its position as a top player in the industry. Its 1-year performance has been impressive, with a 77.63% increase compared to the Sensex's 17.34% performance.
Alpa Laboratories' success can be attributed to its strong management team, innovative products, and strategic partnerships. With a focus on quality and customer satisfaction, the company is poised for continued growth and success in the future.
Investors looking for a promising microcap stock in the pharma industry should definitely keep an eye on Alpa Laboratories. Its recent performance and positive outlook make it a strong contender for long-term investment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
